Pharma · Development
Personalized Solutions for Pharma Development
We help development teams turn promising research into scalable, validated processes through tailored organizational, digital and technical solutions.
5× daily processing capacity Automated Compound Hub · Swiss biopharma client
01 · the phase
Development is where promising science meets process reality, and where scale-up surprises, tech-transfer overhead and validation rework eat timelines. We know these bottlenecks and prove which one is worth moving with a 4-week PoC, before it threatens a Phase-III milestone.
02 · what we hear
Key challenges, and how AI-driven transformation helps.
- Scale-up risk Challenge
The process works at bench scale and nobody is certain it holds at pilot scale. Transferring to the next site means rebuilding batch records by hand from documents written for a different plant, and the assumptions that do not survive the move only surface in the campaign after.
How we helpWe identify the risk areas along technology transfer that would otherwise surface at Phase III, and provide a validation-ready path built for successful scaling.
- Mapping data across targets Challenge
Sequence and structure data is spread across project reports and instrument exports, so checking whether a related target has already been characterised means opening file after file instead of running a query.
How we helpWe develop knowledge graphs that amalgamate and analyse the various layers of data, helping pinpoint which sequences and structures connect to new disease-related targets.
03 · use cases